The ε4 allele of the apolipoprotein E (APOE) gene is known as a risk factor for dementia. How APOE ε polymorphism affects cognitive performance in nondemented aging subjects remains less clear. In this study, the relationship between APOE status and cognitive performance across various cognitive domains in adults aged 55 to 75 years (n = 74) without dementia was investigated. E4 carriers (n = 11) performed worse versus noncarriers on forward Digit Span and delayed recall of the Rey-Osterrieth complex figure. General linear model analysis revealed a small but significant main effect of ε4 on Rey-Osterrieth complex figure delayed recall. Comparing ε2 carriers, ε3 homozygotes, and ε4 carriers, ε3/ε3 performed significantly better on Trail Making Test part B and derived score Trail Making Test B-A. The findings support the relation between the APOE ε polymorphism and visual memory, short-term auditory memory, visuospatial attention, and executive functions in an aging sample without dementia.
AlbertM.SoldanA.GottesmanR.McKhannG.SacktorN.FarringtonL.SelnesO. (2014) Cognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype. Current Alzheimer Research11: 773–784.
2.
AlbinetC. T.BoucardG.BouquetC. A.AudiffrenM. (2012) Processing speed and executive functions in cognitive aging: How to disentangle their mutual relationship?Brain Cognition79: 1–11.
3.
Arendt, T., Schindler, C., Brückner, M. K., Eschrich, K., Bigl, V., Zedlick, D., & Marcova, L. (1997). Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele. Journal of Neuroscience, 17, 516 529.
4.
BerryD. T.CarpenterG. S. (1992) Effect of four different delay periods on recall of the Rey-Osterrieth complex figure by older persons. Journal of Clinical Neuropsychologist6: 80–84.
5.
BlairC. K.FolsomA. R.KnopmanD. S.BrayM. S.MosleyT. H.BoerwinkleE. (2005) Atherosclerosis risk in communities (ARIC) study investigators. APOE genotype and cognitive decline in a middle-aged cohort. Neurology64: 268–276.
6.
Bonner-JacksonA.OkonkwoO.TremontG. (2012) Alzheimer's disease neuroimaging initiative. Apolipoprotein E ε2 and functional decline in amnestic mild cognitive impairment and Alzheimer disease. The American Journal of Geriatric Psychiatry20: 584–593.
7.
CanellopoulouM.RichardsonJ. T. (1998) The role of executive function in imagery mnemonics: Evidence from multiple sclerosis. Neuropsychologia36: 1181–1188.
8.
Carrión-BaraltJ. R.Meléndez-CabreroJ.Rodríguez-UbiñasH.SchmeidlerJ.BeeriM. S.AngeloG.SilvermanJ. M. (2009) Impact of APOE epsilon4 on the cognitive performance of a sample of non-demented Puerto Rican nonagenarians. Journal of Alzheimer's Disease18: 533–540.
9.
CaselliR. J.DueckA. C.OsborneD.SabbaghM. N.ConnorD. J.AhernG. L.ReimanE. M. (2009) Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. The New England Journal of Medicine361: 255–263.
10.
CaselliR. J.ReimanE. M.LockeD. E.HuttonM. L.HentzJ. G.Hoffman-SnyderC.OsborneD. (2007) Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment. Archives of Neurology64: 1306–1311.
11.
Caselli, R. J., Reiman, E. M., Osborne, D., Hentz, J. G., Baxter, L. C., Hernandez, J. L., & Alexander, G. G. (2004). Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele. Neurology, 62, 1990–1995.
12.
ChristensenK.JohnsonT. E.VaupelJ. W. (2006) The quest for genetic determinants of human longevity: Challenges and insights. Nature Reviews Genetics7: 436–448.
13.
CorboR. M.ScacchiR. (1999) Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a ‘thrifty’ allele?Annals of Human Genetics63: 301–310.
14.
CorderE. H.SaundersA. M.StrittmatterW. J.SchmechelD. E.GaskellP. C.SmallG. W.Pericak-VanceM. A. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science261: 921–923.
15.
Darst, B. F., Koscik, R. L., Hermann, B. P., La Rue, A., Sager, M. A., Johnson, S. C., & Engelman, C. D. (2015). Heritability of cognitive traits among siblings with a parental history of Alzheimer s disease. Journal of Alzheimer s Disease, 45, 1149–1155.
16.
DaviesG.ArmstrongN.BisJ. C.BresslerJ.ChourakiV.GiddaluruS.DearyI. J. (2015) Genetic contributions to variation in general cognitive function: A meta-analysis of genome-wide association studies in the CHARGE consortium (N=53949). Molecular Psychiatry20: 183–192.
17.
DaviesG.HarrisS. E.ReynoldsC. A.PaytonA.KnightH. M.LiewaldD. C.DearyI. J. (2014) A genome-wide association study implicates the APOE locus in nonpathological cognitive ageing. Molecular Psychiatry19: 76–87.
18.
DavignonJ.CohnJ. S.MabileL.BernierL. (1999) Apolipoprotein E and atherosclerosis: Insight from animal and human studies. Clinica Chimica Acta286: 115–143.
19.
den HeijerT.OudkerkM.LaunerL. J.van DuijnC. M.HofmanA.BretelerM. M. (2002) Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology59: 746–748.
20.
DevanandD. P.PeltonG. H.ZamoraD.LiuX.TabertM. H.GoodkindM.MayeuxR. (2005) Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. Archives of Neurology62: 975–980.
21.
DuffK.SchoenbergM. R.ScottJ. G.AdamsR. L. (2005) The relationship between executive functioning and verbal and visual learning and memory. Archives of Clinical Neuropsychology20: 111–122.
22.
Elias-SonnenscheinL. S.ViechtbauerW.RamakersI. H.VerheyF. R.VisserP. J. (2011) Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: A meta-analysis. Journal of Neurology, Neurosurgery, and Psychiatry82: 1149–1156.
23.
FanM.LiuB.ZhouY.ZhenX.XuC.JiangT. (2010) Cortical thickness is associated with different apolipoprotein E genotypes in healthy elderly adults. Neuroscience Letters479: 332–336.
24.
FarrerL. A.CupplesL. A.HainesJ. L.HymanB.KukullW. A.MayeuxR.van DuijnC. M. (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta analysis consortium. JAMA278: 1349–1356.
25.
FloryJ. D.ManuckS. B.FerrellR. E.RyanC. M.MuldoonM. F. (2000) Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults. American Journal of Medical Genetics96: 707–711.
26.
GerdesL. U.JeuneB.RanbergK. A.NyboH.VaupelJ. W. (2000) Estimation of apolipoprotein E genotype-specific relative mortality risks from the distribution of genotypes in centenarians and middle-aged men: Apolipoprotein E gene is a “frailty gene,” not a “longevity gene”. Genetic Epidemiology19: 202–210.
27.
GiauV. V.BagyinszkyE.AnS. S.KimS. Y. (2015) Role of apolipoprotein E in neurodegenerative diseases. Neuropsychiatric Disease and Treatment11: 1723–1737.
28.
GreenowK.PearceN. J.RamjiD. P. (2005) The key role of apolipoprotein E in atherosclerosis. Journal of Molecular Medicine83: 329–342.
29.
GreenwoodP. M.SunderlandT.FrizJ. L.ParasuramanR. (2000) Genetics and visual attention: Selective deficits in healthy adult carriers of the epsilon 4 allele of the apolipoprotein E gene. Proceedings of the National Academy of Sciences of the United States of America97: 11661–11666.
30.
HanS. D.BondiM. W. (2008) Revision of the apolipoprotein E compensatory mechanism recruitment hypothesis. Alzheimers and Dementia4: 251–254.
31.
HendersonA. S.EastealS.JormA. F.MackinnonA. J.KortenA. E.ChristensenH.JacombP. A. (1995) Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample. Lancet346: 1387–1390.
32.
Hyman, B. T., Gomez-Isla, T., Briggs, M., Chung, H., Nichols, S., Kohout, F., & Wallace, R. (1996). Apolipoprotein E and cognitive change in an elderly population. Annals of Neurology, 40, 55–66.
33.
Iacono, D., Zandi, P., Gross, M., Markesbery, W. R., Pletnikova, O., Rudow, G., & Troncoso, J. C. (2015). APOe2 and education in cognitively normal older subjects with high levels of AD pathology at autopsy: Findings from the Nun Study. Oncotarget, 6, 14082–14091.
34.
Jacobsen, R., Martinussen, T., Christiansen, L., Jeune, B., Andersen-Ranberg, K., Vaupel, J. W., & Christensen, K. (2010). Increased effect of the ApoE gene on survival at advanced age in healthy and long-lived Danes: Two nationwide cohort studies. Aging Cell, 9, 1004–1009.
35.
JansenW. J.OssenkoppeleR.KnolD. R.TijmsB. M.ScheltensP.VerheyF. R.ZetterbergH. (2015) Prevalence of cerebral amyloid pathology in persons without dementia. A meta-analysis. JAMA313: 1924–1938.
36.
KnopmanD. S.MosleyT. H.CatellierD. J.CokerL. H. (2009) Atherosclerosis risk in communities study brain MRI Study. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: The ARIC MRI study. Alzheimer's and Dementia5: 207–214.
37.
KowalskaA.WiechmannI.WalterH. (1998) Genetic variability of apolipoprotein E in a Polish population. Human Biology70: 1093–1099.
38.
LancasterC.TabetN.RustedJ. (2016) The APOE paradox: Do attentional control differences in mid-adulthood reflect risk of late-life cognitive decline. Neurobiology of Aging48: 114–121.
39.
LezakM. D.HowiesonD. B.BiglerE. D.TranelD. (2012) Neuropsychological assessment, New York, NY: Oxford University Press.
40.
LiL.BaoY.HeS.WangG.GuanY.MaD.YangJ. (2015) The association between apolipoprotein e and functional outcome after traumatic brain injury: A meta-analysis. Medicine (Baltimore)94: e2028, doi:10.1097/MD.0000000000002028.
41.
LimY. Y.EllisK. A.PietrzakR. H.AmesD.DarbyD.HarringtonK.MaruffP,AIBL Research Group (2012) Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults. Neurology79: 1645–1652.
42.
LiuC. C.KanekiyoT.XuH.BuG. (2013) Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy. Nature Reviews Neurology9: 106–118.
43.
Liu, Y., Paajanen, T., Westman, E., Zhang, Y., Wahlund, L. O., Simmons, A., … AddNeuroMed Consortium. (2010). APOE ε2 allele is associated with larger regional cortical thicknesses and volumes. Dementia and Geriatric Cognitive Disorders, 30, 229–237.
44.
LucianoM.GowA. J.TaylorM. D.HaywardC.HarrisS. E.CampbellH.DearyIJ (2009) Apolipoprotein E is not related to memory abilities at 70 years of age. Behavior Genetics39: 6–14.
45.
MahleyR. W. (1988) Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science240: 622–630.
46.
MahleyR. W.WeisgraberK. H.HuangY. (2009) Apolipoprotein E: Structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. Journal of Lipid Research50: S183–S188.
47.
MarioniR. E.CampbellA.ScotlandG.HaywardC.PorteousD. J.DearyI. J. (2016) Differential effects of the APOE e4 allele on different domains of cognitive ability across the life-course. European Journal of Human Genetics24: 919–923.
48.
Mauch, D. H., Nägler, K., Schumacher, S., Göritz, C., Müller, E. C., Otto, A., & Pfrieger, F. W. (2001). CNS synaptogenesis promoted by glia-derived cholesterol. Science, 294, 1354–1357.
49.
MielkeM. M.MachuldaM. M.HagenC. E.ChristiansonT. J.RobertsR. O.KnopmanD. S.PetersenR. C. (2016) Influence of amyloid and APOE on cognitive performance in a late middle-aged cohort. Alzheimer's Dementia12: 281–291.
50.
NegashS.GreenwoodP. M.SunderlandT.ParasuramanR.GedaY. E.KnopmanD. S.SmithG. E. (2009) The influence of apolipoprotein E genotype on visuospatial attention dissipates after age 80. Neuropsychology23: 81–89.
51.
NilssonL. G.NybergL.BäckmanL. (2002) Genetic variation in memory functioning. Neuroscience and Biobehavioral Reviews26: 841–848.
52.
NorbergJ.GraffC.AlmkvistO.EwersM.FrisoniG. B.FrölichL.VisserP. J. (2011) Regional differences in effects of APOE ε4 on cognitive impairment in non-demented subjects. Dementia and Geriatric Cognitive Disorders32: 135–142. doi:10.1159/000330492.
53.
O'HaraR.YesavageJ. A.KraemerH. C.MauricioM.FriedmanL. F.MurphyG. M.Jr (1998) The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults. Journal of the American Geriatrics Society46: 1493–1498.
54.
PanzaF.SolfrizziV.TorresF.MastroianniF.Del ParigiA.ColaciccoA. M.CapursoA. (1999) Decreased frequency of apolipoprotein E ε4 allele from Northern to Southern Europe in Alzheimer's disease patients and centenarians. Neuroscience Letters277: 53–56.
55.
RubinoE.VaccaA.GovoneF.De MartinoP.PinessiL.RaineroI. (2013) Apolipoprotein E polymorphisms in frontotemporal lobar degeneration: A meta-analysis. Alzheimer's Dementia9: 706–713.
56.
Sadigh-EteghadS.TalebiM.FarhoudiM. (2012) Association of apolipoprotein E epsilon 4 allele with sporadic late onset Alzheimer’s disease. A meta-analysis. Neurosciences17: 321–326.
57.
SaloA.YlikoskiR.VerkkoniemiA.PolvikoskiT.JuvaK.RastasS.SulkavaR. (2001) Does apolipoprotein E influence learning and memory in the nondemented oldest old?International Psychogeriatrics13: 451–459.
58.
SalthouseT. A. (1995) Selective influences of age and speed on associative memory. The American Journal of Psychology108: 381–396.
59.
SalthouseT. A. (1996) The processing-speed theory of adult age differences in cognition. Psychological Review103: 403–428.
60.
Sanchez-Cubillo, I., Perianez, J. A., Adrover-Roig, D., Rodriguez-Sanchez, J. M., Rios-Lago, M., Tirapu, J., & Barcelo, F. (2009). Construct validity of the Trail Making Test: Role of task-switching, working memory, inhibition/interference control, and visuomotor abilities. Journal of International Neuropsychological Society, 15, 438–450.
61.
SavitzJ.SolmsM.RamesarR. (2006) Apolipoprotein E variants and cognition in healthy individuals: A critical opinion. Brain Research Review51: 125–135.
62.
SchultzM. R.LyonsM. J.FranzC. E.GrantM. D.BoakeC.JacobsonK. C.KremenW. S. (2008) Apolipoprotein E genotype and memory in the sixth decade of life. Neurology70: 1771–1777.
63.
Serrano-PozoA.QianJ.MonsellS. E.BetenskyR. A.HymanB. T. (2015) APOEε2 is associated with milder clinical and pathological Alzheimer disease. Annals of Neurology77: 917–929.
64.
SmallB. J.GravesA. B.McEvoyC. L.CrawfordF. C.MullanM.MortimerJ. A. (2000) Is APOE—Epsilon4 a risk factor for cognitive impairment in normal aging?Neurology54: 2082–2088.
65.
SmallB. J.RosnickC. B.FratiglioniL.BäckmanL. (2004) Apolipoprotein E and cognitive performance: A meta-analysis. Psychological Aging19: 592–600.
66.
SmithL. C.PownallH. J.GottoA. M.Jr (1978) The plasma lipoproteins: Structure and metabolism. Annual Review of Biochemistry47: 751–757.
67.
StraussE.ShermanE. M. S.SpreenO. (2006) A compendium of neuropsychological tests: Administration, norms, and commentary, New York, NY: Oxford University Press.
68.
SunS.FuJ.ChenJ.PangW.HuR.LiH.JiangY. (2015) ApoE type 4 allele affects cognitive function of aged population in Tianjin City, China. American Journal of Alzheimer's Disease and Other Dementia30: 503–507.
69.
TaylorE. M. (1959) Psychological appraisal of children with cerebral defects, Cambridge, MA: Harvard University Press.
70.
TempleR. O.DavisJ. D.SilvermanI.TremontG. (2006) Differential impact of executive function on visual memory tasks. The Clinical Neuropsychologist20: 480–490.
71.
TeterB.XuP. T.GilbertJ. R.RosesA. D.GalaskoD.ColeG. M. (2002) Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function. Journal of Neuroscience Research68: 331–336.
72.
TsuangD.LeverenzJ. B.LopezO. L.HamiltonR. L.BennettD. A.SchneiderJ. A.ZabetianC. P. (2013) APOE ε4 increases risk for dementia in pure synucleinopathies. JAMA Neurololgy70: 223–228.
73.
VerpillatP.CamuzatA.HannequinD.Thomas-AnterionC.PuelM.BelliardS.Clerget-DarpouxF. (2002) Apolipoprotein E gene in frontotemporal dementia: an association study and meta-analysis. European Journal of Human Genetics10: 399–405.
74.
WestH. L.RebeckG. W.HymanB. T. (1994) Frequency of the apolipoprotein E epsilon 2 allele is diminished in sporadic Alzheimer disease. Neuroscience Letters175: 46–48.
75.
WhiteF.NicollJ. A.RosesA. D.HorsburghK. (2001) Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion. Neurobiology of Disease8: 611–625.
76.
WilsonR. S.BieniasJ. L.Berry-KravisE.EvansD. A.BennettD. A. (2002) The apolipoprotein E epsilon 2 allele and decline in episodic memory. Journal of Neurology, Neurosurgery, and Psychiatry73: 672–677.
77.
WilsonR. S.SchneiderJ. A.BarnesL. L.BeckettL. A.AggarwalN. T.CochranE. J.BennettD. A. (2002) The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Archives of Neurology59: 1154–1160.
78.
WisdomN. M.CallahanJ. L.HawkinsK. A. (2011) The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis. Neurobiology of Aging32: 63–74.
79.
YaffeK.CauleyJ.SandsL.BrownerW. (1997) Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women. Archives of Neurology54: 1110–1114.
80.
YinY. W.LiJ. C.WangJ. Z.LiB. H.PiY.YangQ. W.ZhangL. L. (2012) Association between apolipoprotein E gene polymorphism and the risk of vascular dementia: A meta-analysis. Neuroscience Letters514: 6–11.
81.
YipA. G.BrayneC.EastonD.RubinszteinD. C. (2002) Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population. Journal of Medical Genetics39: 639–643.
82.
ZehnderA. E.BläsiS.BerresM.MonschA. U.StähelinH. B.SpiegelR. (2009) Impact of APOE status on cognitive maintenance in healthy elderly persons. International Journal of Geriatric Psychiatry24: 132–141.
